Generic drugmaker Sandoz to engage with US after Trump tariff threat

Swiss generic drugmaker Sandoz said on Wednesday it would continue discussions with policymakers after U.S. President Donald ​Trump threatened the industry with steep tariffs unless drugmakers ‌manufacture medicines domestically.